Skip to main content
. 2011 Sep 1;89(11):821–830B. doi: 10.2471/BLT.11.089862

Table 2. Survey samples used for assessing human papillomavirus (HPV) vaccination coverage in demonstration projects, India, Peru, Uganda and Viet Nam, 2008–2010.

Country Vaccine delivery strategy Vaccination year Estimated vaccination coverage (%) No. of clusters × no. of girls Sample size (n)
Expected Final Final for analysis
Peru School-based 2008 80 70 × 8 560 580 575a
Uganda School-based 2008 85 40 × 10 400 400 400b
2009 90 28 × 10 280 280 280
Combined with Child Days Plus programme 2008–2009 85 40 × 10 400 400 361c
2009 70 80 × 8 640 640 448d
Viet Nam School-based 2008–2009 80 20 × 25 500 500 500
2009–2010 95 NAe 285 285 285
Health-centre-based 2008–2009 90 20 × 14 280 280 280
2009–2010 95 NAe 219 219 219
India School- and health-centre-based, pulsed campaign at three time points 2009–2010 70 132 × 15 1980f 1976 1948g
School- and health-centre-based, monthly delivery 2009–2010 70 132 × 15 1980f 1980 1973h
Total 7585 7540 7269

NA, not applicable.

a The analysis excluded five survey responses because the girls were not in the fifth school grade, as required by the vaccination strategy.

b School grades were missing for four girls but were assumed to be grade five.

c The analysis excluded 39 survey responses because the girls who were vaccinated were not 10 years old, as required by the vaccination strategy.

d The analysis excluded 192 survey responses because either the girls who were vaccinated were not 10 years old, as required by the vaccination strategy, or the girl was actually vaccinated in the first year of the programme rather than the second.

e Systematic random sampling from a complete census of all eligible households was used in the second year.

f There were 660 girls in each of three urban blocks.

g The analysis excluded 28 survey responses because the girls who were vaccinated were not aged between 10 and 14 years, as required by the vaccination strategy.

h The analysis excluded seven survey responses because the girls who were vaccinated were not aged between 10 and 14 years, as required by the vaccination strategy.